Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Heatwaves
South America
Social Media
Wrestling
Latin America
Stock Markets
Donald Trump
Artificial Intelligence
Senate
NATO
World Cup
Soccer
European-biotechnology.com image

News from european-biotechnology.com

If you want to know if European-biotechnology.com is credible or reliable, look no further. We rank European-biotechnology.com as Unknown factuality. Find out more about our methodology here.

Information about European-biotechnology.com

Where is European-biotechnology.com located?European-biotechnology.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top European-biotechnology.com News

EU halts talks on law tackling companies' fake 'green' claims
European Union · Brussels

EU halts talks on law tackling companies' fake 'green' claims

38% Center coverage: 16 sources
See the Story
New biosecurity centre to tackle pandemics and animal disease gets £1bn funding
Pandemic · Weybridge

New biosecurity centre to tackle pandemics and animal disease gets £1bn funding

57% Left coverage: 7 sources
The announcement is part of a new national security strategy.See the Story
Várhelyi announces Biotech Act is set for 2025 after all
European Union · Brussel

Várhelyi announces Biotech Act is set for 2025 after all

100% Left coverage: 1 sources
The highly anticipated act is back on the table for the end of this year due to "global challenges".See the Story

Blindspots

Blindspot:
23 sources

New biosecurity centre to tackle pandemics and animal disease gets £1bn funding

Left57%
Center29%
Right14%

Sonrai and Plectonic to Advance Cancer Immunotherapies

100% Center coverage: 1 sources
The collaboration will aim to positively impact treatment across a range of cancers. Read more: Sonrai and Plectonic to advance cancer immunotherapiesDublin, Ireland · DublinSee the Story

New CEO – new chapter - European Biotechnology Magazine

MC2 Therapeutics A/S, a Hørsholm-based pharmaceutical company focused on topical therapies in inflammatory skin conditions, announced the appointment of Trine Ahlgreen as Chief Executive Officer at the end of May. The post New CEO – new chapter appeared first on European Biotechnology Magazine.Pharma · DenmarkRead Article

Cellular Origines partners with Johnson & Johnson - European Biotechnology Magazine

British gene and cell therapy manufacturing specialist Cellular Origins Ltd has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform for autologous CAR-T cell manufacturing. The post Cellular Origines partners with Johnson & Johnson appeared first on European Biotechnology Magazine.United Kingdom · United KingdomRead Article

Rapid progress in cultivated meat - European Biotechnology Magazine

Cultivated meat is expected to reach price parity with conventional meat sooner than previously forecast, according to a new analysis by technology foresight specialist GetFocus. The post Rapid progress in cultivated meat appeared first on European Biotechnology Magazine.Germany · GermanySee the Story

Mabion Launches €500,000 Services Contest to Support Next-Gen Oncology Advances

Mabion, a CDMO based in Poland, launched a €500,000 ($574,000) oncology services contest at the BIO International Convention aimed at accelerating the development of recombinant protein-based cancer therapies. The contest will culminate at CPHI Worldwide in Frankfurt this October, spotlighting promising biotechs ready to scale their innovation. “Despite unprecedented scientific advances, many oncology treatments still face hurdles at the funding…Cancer · PolandSee the Story

French Afyren starts production of bio-acids – CEO in interview - European Biotechnology Magazine

AFYREN’s first biorefinery, AFYREN NEOXY, has reached continuous production, marking a key step toward large-scale commercialization of its bio-based acids. The plant will now ramp up output and fulfill long-term contracts across key sectors like nutrition, cosmetics, and life sciences. European Biotech News talked to CEO Nicolas Sordet about the long and winding road to sucess. The post French Afyren starts production of bio-acids – CEO in inte…France · FranceRead Article

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines

100% Center coverage: 5 sources
Financing co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investorsProceeds will support clinical development of lead program SB-007 in Stargardt diseaseFunding will also advance a broader pipeline…StartupsSee the Story

EQT Leads Investment in Mosanna to Advance Nasal Spray Therapy for Sleep Apnea Patients

Open the article to view the coverage from EuropaWire.euTechnologySee the Story

Breaking News Topics Related to European-biotechnology.com

Pandemic icon

Pandemic

Switzerland icon

Switzerland

Innovation icon

Innovation

Hamburg, Germany icon

Hamburg, Germany

France icon

France

Germany icon

Germany

European Union icon

European Union

United Kingdom icon

United Kingdom

News
For You
SearchBlindspotLocal